JP2016011272A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016011272A5 JP2016011272A5 JP2014133377A JP2014133377A JP2016011272A5 JP 2016011272 A5 JP2016011272 A5 JP 2016011272A5 JP 2014133377 A JP2014133377 A JP 2014133377A JP 2014133377 A JP2014133377 A JP 2014133377A JP 2016011272 A5 JP2016011272 A5 JP 2016011272A5
- Authority
- JP
- Japan
- Prior art keywords
- microrna
- control agent
- immune response
- response control
- function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108700011259 MicroRNAs Proteins 0.000 claims 5
- 239000002679 microRNA Substances 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 210000004443 dendritic cell Anatomy 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 238000005316 response function Methods 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000016396 cytokine production Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014133377A JP6385732B2 (ja) | 2014-06-27 | 2014-06-27 | 免疫応答制御剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014133377A JP6385732B2 (ja) | 2014-06-27 | 2014-06-27 | 免疫応答制御剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016011272A JP2016011272A (ja) | 2016-01-21 |
| JP2016011272A5 true JP2016011272A5 (enExample) | 2018-03-01 |
| JP6385732B2 JP6385732B2 (ja) | 2018-09-05 |
Family
ID=55228217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014133377A Active JP6385732B2 (ja) | 2014-06-27 | 2014-06-27 | 免疫応答制御剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6385732B2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6566612B2 (ja) * | 2014-06-27 | 2019-08-28 | 国立大学法人北海道大学 | 免疫体質又は免疫応答型を判定するためのバイオマーカー及び免疫応答型制御剤 |
| CN108853132A (zh) * | 2018-05-22 | 2018-11-23 | 深圳先进技术研究院 | 一种miR-340调控IL-17A表达的用途 |
| US20220177967A1 (en) * | 2019-03-08 | 2022-06-09 | Edward E. Winger, M.D., Professional Corporation | Reagents, methods and kits for identifying pregnant human beings at risk for placental bed disorder(s) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2475372B2 (en) * | 2009-09-10 | 2020-10-21 | Velin-Pharma A/S | Method for the preparation of micro-rna and its therapeutic application |
| US20140080894A1 (en) * | 2011-03-02 | 2014-03-20 | David L. McElligott | Enhanced biodistribution of oligomers |
| US9725721B2 (en) * | 2012-09-26 | 2017-08-08 | Mirrx Therapeutics | Oligomers with improved off-target profile |
| CA2892529C (en) * | 2012-11-26 | 2023-04-25 | Moderna Therapeutics, Inc. | Terminally modified rna |
-
2014
- 2014-06-27 JP JP2014133377A patent/JP6385732B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014237817A5 (enExample) | ||
| HK1254948A1 (zh) | 源自间充质干细胞的外泌体及其应用 | |
| JP2017514877A5 (enExample) | ||
| EP4374863A3 (en) | Methods for generating stem cell-derived beta cells and uses thereof | |
| JP2014221779A5 (enExample) | ||
| WO2015011694A3 (en) | Isotopologues of smad7 antisense oligonucleotides | |
| WO2017070626A3 (en) | Respiratory virus vaccines | |
| EP4269601A3 (en) | Modified t cells and methods of making and using the same | |
| MX2016014320A (es) | Composiciones de suspension de liberacion prolongada. | |
| MX2015012414A (es) | Sal de omecamtiv mecarbilo y proceso para preparar la sal. | |
| JP2017537928A5 (enExample) | ||
| IL262944A (en) | Viral particle for rna transfer, especially into cells involved in immune response | |
| EP3162372A4 (en) | Composition for treating ischemic diseases or neurogenic inflammation, containing, as active ingredient, neural progenitor cells or secretome thereof | |
| WO2016011049A3 (en) | Compositions and methods for disease treatment using nanoparticle delivered compounds | |
| JP2016540026A5 (enExample) | ||
| JP2016540019A5 (enExample) | ||
| MX2014012164A (es) | Composiciones a base de probioticos y un complejo de polen de abejas/arcilla, su preparacion y sus usos en nutricion y en terapeutica. | |
| WO2015173701A3 (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases | |
| WO2016095934A3 (en) | A novel genetic device to engineer cell behavior | |
| JP2016011272A5 (enExample) | ||
| WO2016141320A3 (en) | Non-neuroinvasive viruses and uses thereof | |
| ZA201806766B (en) | Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof | |
| FR3017029B1 (fr) | Principe actif nutritionnel obtenu a partir de vaccinium angustifolium, composition le contenant et utilisation | |
| HUE037543T2 (hu) | Di-homo-gamma linolénsavat (DGLA) tartalmazó liposzómák, az azokat tartalmazó készítmények és alkalmazásuk | |
| JP2018070453A5 (enExample) |